Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Genomic Characterization of Paired Diagnosis and Relapse Samples from Adult Patients with B-Cell Precursor Acute Lymphoblastic Leukemia

Blood (2016) 128 (22): 5281.

https://doi.org/10.1182/blood.V128.22.5281.5281

Published: 2016

Journal Articles

Mutational Studies Using Next Generation Sequencing in High Risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia Patients Treated with Azacitidine (High risk MDS 2009 protocol from CETLAM Group)

Blood (2015) 126 (23): 2905.

https://doi.org/10.1182/blood.V126.23.2905.2905

Published: 2015

Journal Articles

Methylation Patterns in Patients with High-Risk Myelodysplatic Syndromes and Secondary Acute Myeloid Leukemia Treated with Azacitidine (high-risk MDS 2009 protocol from CETLAM Group)

Blood (2015) 126 (23): 1682.

https://doi.org/10.1182/blood.V126.23.1682.1682

Published: 2015

Journal Articles

Molecular Genetic Profiling in Chronic Myelomonocytic Leukemia with Low Risk Cytogenetic Features

Laura Palomo, MSc, Blanca Xicoy, MD PhD, Montse Arnan, MD, Marta Cabezon, Rosa Coll, MD, Vera Ademà, MSc, Francisco Fuster, MSc, Javier Grau, MD, María José Jiménez, Helena Pomares, MD, Sílvia Marcé, PhD, Maria Pilar Armengol, PhD, Mar Mallo, PhD, Fuensanta Millá, MD PhD, Evarist Feliu, MD PhD, Francesc Sole, PhD, Lurdes Zamora, PhD

Blood (2015) 126 (23): 2883.

https://doi.org/10.1182/blood.V126.23.2883.2883

Published: 2015

Journal Articles

Utility of SNP Arrays in Chronic Myelomonocytic Leukemia with Low Risk Cytogenetic Features or No Metaphases

Blood (2014) 124 (21): 4659.

https://doi.org/10.1182/blood.V124.21.4659.4659

Published: 2014

Journal Articles

Frequency and Prognosis of JAK2 V617F, Calr , MPL and ASXL1 Mutations in Primary Myelofibrosis

Marc Sorigue, MD, Marta Cabezón, Olga Garcia, Patricia Velez, MD, Silvia Marce, PhD, Concha Boqué, MD PhD, Blanca Xicoy, MD PhD, Cristalina Fernandez, MD, Marisol Xandri, Enric Casanova, David Gallardo, MD PhD, Fuensanta Milla, MD PhD, Josep-Maria Ribera, MD PhD, Evarist Feliu, MD PhD, Lurdes Zamora, PhD

Blood (2014) 124 (21): 5562.

https://doi.org/10.1182/blood.V124.21.5562.5562

Published: 2014

Journal Articles

Genetic Markers Add Significant Prognostic Information to Age and WBC Count in High-Risk, Ph-Negative, B-Precursor Adult Acute Lymphoblastic Leukemia (ALL): Study of 96 Patients Treated According to Risk-Adapted Protocols from the Pethema Group

Blood (2014) 124 (21): 3798.

https://doi.org/10.1182/blood.V124.21.3798.3798

Published: 2014

Journal Articles

Lymphomas With MYC -Translocation Other Than Burkitt’s Have An Aggressive Presentation and Poor Response To Immunochemotherapy: Study Of 34 Cases

Jose-Tomas Navarro, MD, PhD, Maria Joao Baptista, PhD, Alejandra Martinez-Trillos, MD, Gustavo Tapia, MD, Jose Angel Hernandez-Rivas, MD, PhD, Olga Garcia, Anna Muñoz-Marmol, PhD, Juan-Manuel Sancho, MD, PhD, Fuensanta Millá, MD, PhD, Evarist Feliu, MD, PhD, Jose-Luis Mate, MD, PhD, Armando Lopez-Guillermo, MD, PhD, Josep-Maria Ribera, MD, PhD

Blood (2013) 122 (21): 5083.

https://doi.org/10.1182/blood.V122.21.5083.5083

Published: 2013

Journal Articles

Prognostic Significance Of Copy Number Alterations In B-Lineage Adult Acute Lymphoblastic Leukemia Patients Enrolled In Risk-Adapted Protocols From The Pethema Group

Blood (2013) 122 (21): 2556.

https://doi.org/10.1182/blood.V122.21.2556.2556

Published: 2013

Journal Articles

Clinical and Biological Features Of Monoclonal B-Cell Lymphocytosis In Patients Referred To Hospital

Ines Rodriguez-Hernandez, Jordi Junca, MD, Jose-Tomas Navarro, MD, PhD, Isabel Granada, Evarist Feliu, MD, PhD, Fuensanta Milla, MD, PhD, Josep-Maria Ribera, MD, PhD

Blood (2013) 122 (21): 5298.

https://doi.org/10.1182/blood.V122.21.5298.5298

Published: 2013

Journal Articles

Differences In Clinical-Biological Features and Outcome Between Diffuse Large B-Cell Lymphomas Of HIV-Infected and Non-HIV-Infected Patients Treated With RCHOP In The CART Era

Maria Joao Baptista, PhD, Mireia Morgades, Olga Garcia, Miriam Moreno, MD, Juan Manuel Sancho, MD, PhD, Fuensanta Millá, MD, PhD, Evarist Feliu, MD, PhD, Josep-Maria Ribera, MD, PhD, Jose-Tomas Navarro, MD, PhD

Blood (2013) 122 (21): 1815.

https://doi.org/10.1182/blood.V122.21.1815.1815

Published: 2013

Journal Articles

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group

Blood (2010) 116 (9): 1479–1488.

https://doi.org/10.1182/blood-2010-02-267476

Published: 2010

Includes: Supplemental data

Journal Articles

Severe Myelodysplasia with Monosomy 7 Developing during Imatinib Treatment of Philadelphia-Positive Chronic Myeloid Leukemia: Two Cases Evolving with Different Outcome.

José-Tomás Navarro, PhD, Evarist Feliu, PhD, Javier Grau, MD, Dolors Colomer, PhD, Blanca Espinet, PhD, Isabel Granada, Blanca Xicoy, MD, Elisa Orna, MD, Albert Oriol, MD, Natalia Lloveras, MD, Jordi Junca, PhD, Josep-Maria Ribera, PhD, Fuensanta Milla, MD

Blood (2005) 106 (11): 4861.

https://doi.org/10.1182/blood.V106.11.4861.4861

Published: 2005

Journal Articles

The History of 34 Errors Identified in 874 Patients Analyzed at Weekly Clinical-Pathological Meetings in Two Institutions over 22 Years (1982–2004).

Evarist Feliu, MD, Blanca Xicoy, MD, Maria Rozman, MD, Fuensanta Milla, MD, Josep-Lluis Aguilar, MD, Jose-Luis Mate, MD, Jose-Lluis Vives, MD, Josep-Maria Ribera, MD, Elias Campo, MD, Jordi Junca, MD, Neus Villamor, MD, Isabel Granada, MD, Dolors Colomer, MD, Jose-Tomas Navarro, MD, Ciril Rozman, MD

Blood (2004) 104 (11): 5287.

https://doi.org/10.1182/blood.V104.11.5287.5287

Published: 2004

Journal Articles

Differential Cytogenetic Pattern of Splenic Marginal Zone B-Cell Lymphoma CD5 Positive Versus CD5 Negative. Preliminary Results.

Eva Gimeno, Marta Salido, Isabel Granada, Blanca Espinet, Encarnacion Perez-Vila, Antonio Salar, Carles Besses, Mar Bellido, Alicia Domingo, Fuensanta Milla, Sergi Serrano, Soledad Woessner, Lourdes Florensa, Francesc Sole

Blood (2004) 104 (11): 2272.

https://doi.org/10.1182/blood.V104.11.2272.2272

Published: 2004

NARROW

Genomic Characterization of Paired Diagnosis and Relapse Samples from Adult Patients with B-Cell Precursor Acute Lymphoblastic Leukemia

Mutational Studies Using Next Generation Sequencing in High Risk Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia Patients Treated with Azacitidine (High risk MDS 2009 protocol from CETLAM Group)

Methylation Patterns in Patients with High-Risk Myelodysplatic Syndromes and Secondary Acute Myeloid Leukemia Treated with Azacitidine (high-risk MDS 2009 protocol from CETLAM Group)

Molecular Genetic Profiling in Chronic Myelomonocytic Leukemia with Low Risk Cytogenetic Features

Utility of SNP Arrays in Chronic Myelomonocytic Leukemia with Low Risk Cytogenetic Features or No Metaphases

Frequency and Prognosis of JAK2 V617F, Calr , MPL and ASXL1 Mutations in Primary Myelofibrosis

Genetic Markers Add Significant Prognostic Information to Age and WBC Count in High-Risk, Ph-Negative, B-Precursor Adult Acute Lymphoblastic Leukemia (ALL): Study of 96 Patients Treated According to Risk-Adapted Protocols from the Pethema Group

Lymphomas With MYC -Translocation Other Than Burkitt’s Have An Aggressive Presentation and Poor Response To Immunochemotherapy: Study Of 34 Cases

Prognostic Significance Of Copy Number Alterations In B-Lineage Adult Acute Lymphoblastic Leukemia Patients Enrolled In Risk-Adapted Protocols From The Pethema Group

Clinical and Biological Features Of Monoclonal B-Cell Lymphocytosis In Patients Referred To Hospital

Differences In Clinical-Biological Features and Outcome Between Diffuse Large B-Cell Lymphomas Of HIV-Infected and Non-HIV-Infected Patients Treated With RCHOP In The CART Era

Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group

Severe Myelodysplasia with Monosomy 7 Developing during Imatinib Treatment of Philadelphia-Positive Chronic Myeloid Leukemia: Two Cases Evolving with Different Outcome.

The History of 34 Errors Identified in 874 Patients Analyzed at Weekly Clinical-Pathological Meetings in Two Institutions over 22 Years (1982–2004).

Differential Cytogenetic Pattern of Splenic Marginal Zone B-Cell Lymphoma CD5 Positive Versus CD5 Negative. Preliminary Results.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only